Gradient Investments LLC
Source: SEC Form 13F · as of Mar 2026Gradient Investments LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $211.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$211.2M
| Company | Shares | Value |
|---|---|---|
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 151,888 | $41.1M |
| ABTABBOTT LABORATORIES | 362,674 | $37.2M |
| JNJJOHNSON & JOHNSON | 139,094 | $34.0M |
| AZNASTRAZENECA PLC | 104,776 | $20.7M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 41,736 | $18.6M |
| LLYELI LILLY & Co | 19,585 | $18.0M |
| ABBVAbbVie Inc. | 73,927 | $16.1M |
| AMGNAMGEN INC | 44,623 | $15.7M |
| NVSNovartis AG | 35,153 | $5.4M |
| GMEDGlobus Medical Inc. | 14,030 | $1.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 846 | $654K |
| ACADACADIA PHARMACEUTICALS INC | 28,900 | $643K |
| MRKMerck & Co., Inc. | 3,771 | $454K |
| BMYBRISTOL MYERS SQUIBB CO | 6,221 | $377K |
| MCKMcKesson Corporation | 412 | $357K |
| PFEPFIZER INC | 11,785 | $331K |
| PMPhilip Morris International Inc | 1,995 | $330K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.